Raiffeisen Bank International AG purchased a new stake in shares of Danaher Co. (NYSE:DHR – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 155,956 shares of the conglomerate’s stock, valued at approximately $35,815,000.
Other hedge funds have also recently modified their holdings of the company. Heck Capital Advisors LLC purchased a new stake in Danaher in the fourth quarter worth about $27,000. Decker Retirement Planning Inc. purchased a new stake in Danaher in the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC bought a new stake in Danaher during the 4th quarter worth approximately $31,000. Strategic Financial Concepts LLC purchased a new position in Danaher during the fourth quarter valued at approximately $31,000. Finally, Pineridge Advisors LLC boosted its position in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 57 shares during the period. Institutional investors own 79.05% of the company’s stock.
Insider Transactions at Danaher
In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now directly owns 15,179 shares of the company’s stock, valued at $3,005,442. This trade represents a 51.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the company’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman now owns 3,105,808 shares of the company’s stock, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company’s stock.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on Danaher
Danaher Price Performance
Shares of NYSE:DHR opened at $188.32 on Thursday. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company has a market cap of $134.77 billion, a PE ratio of 35.67, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. The company’s 50 day moving average is $197.35 and its 200 day moving average is $218.33.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The company had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. On average, sell-side analysts forecast that Danaher Co. will post 7.63 EPS for the current year.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.68%. Danaher’s dividend payout ratio is presently 24.85%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
- Five stocks we like better than Danaher
- What Are Dividends? Buy the Best Dividend Stocks
- Is Bally’s Turnaround a Safe Bet Amid Mixed Investor Sentiment?
- What is a SEC Filing?
- Steepening Yield Curve? These 3 Bank Stocks Are Poised to Profit
- How to Invest in Biotech Stocks
- Big Dippers: 3 Stocks Near 1-Year Lows That Could Surge in 2025
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.